Original Source(s)
FDA Clears Golimumab Biosimilars
-
by Kathryn Wighton
May 18, 2026
Related Content
Sex Differences Seen in Immune Cells
Single-cell analysis identified sex-biased immune-cell composition, gene expression, and genetic regulation in unstimulated blood immune cells
May 14, 2026
-
4 min
Serum Urate Goals Tied to Lower CV Risk
Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients
May 11, 2026
-
4 min
Tofacitinib vs Adalimumab Findings Require Caution in RA
Meta-analysis favored tofacitinib for some rheumatoid arthritis outcomes, but high heterogeneity, dose-dependent effects, and JAK inhibitor safety concerns complicate interpretation.
May 8, 2026
-
4 min
